Abstract: A comprehensive system for assisting users of streaming services is provided. The system is implemented in a client/server environment. Users can manage their streaming service credentials, centralize their service information, discover new services and their video content, and share information with their friends and family. Budget and service optimization is provided.

Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising such CNP prodrugs and their uses. In an embodiment, the CNP prodrugs are conjugates of CNP peptides to poly(ethylene glycol) through a reversible linker.

Abstract: A wound treatment system includes a housing. A processor is located in the housing. A pressure monitoring system is coupled to the processor. A power delivery system is located in the housing and coupled to the processor. An oxygen concentrator is located in the housing and coupled to the power delivery system. The oxygen concentrator includes a plurality of oxygen outlets. The processor is configured to receive pressure information from the pressure monitoring system that is indicative of a pressure in a restricted airflow enclosure provided by a dressing and located adjacent a wound site; and use the pressure information to control the power provided from the power delivery system to the oxygen concentrator in order to control an oxygen flow created by the oxygen concentrator and provided through one of the plurality of oxygen outlets to the restricted airflow enclosure.

Abstract: A filter (10) includes a receptacle (12) defining a chamber (14). A granular filtering medium (16) is contained in the chamber (14) of the receptacle (12). A disrupter arrangement (18) is mounted in the chamber (14) of the receptacle (12), the disrupter arrangement (18) serving to disrupt agglomeration of the granular filtering medium (16) within the chamber (14) of the receptacle (12).

Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising such CNP prodrugs and their uses. In an embodiment, the CNP prodrugs are conjugates of CNP peptides to poly(ethylene glycol) through a reversible linker.

Abstract: A wound treatment system includes a housing that defines an oxygen outlet. An oxygen production subsystem is included in the housing and coupled to the oxygen outlet. A control subsystem is coupled to the oxygen production subsystem and configured to receive pressure information that is indicative of a pressure in a restricted airflow enclosure that is coupled to the oxygen outlet. The control subsystem then uses the pressure information to control power provided to the oxygen production subsystem in order to control an oxygen flow that is created by the oxygen production subsystem and provided through the oxygen outlet to the restricted airflow enclosure.

Abstract: A method of monitoring usage of a component of an aircraft can include: monitoring a usage of the component by using a torque measurement system to calculate torque events in a time period; categorizing the usage of the component by assigning a usage value based upon whether the number of torque events in the period of time is above or below a threshold; and determining a life used of the component.

Abstract: A motor vehicle includes a motor vehicle body having an interior forming a passenger compartment. At least one camera is arranged on the outside of the motor vehicle body for imaging an area to the side and behind of the motor vehicle. In the interior of the motor vehicle, particularly in the region of an instrument panel, a monitor or display is arranged in or on an air outlet. The monitor is connected to the camera for continuously displaying the imaged area to occupants, and in particular a driver, in the passenger compartment.

Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising such CNP prodrugs and their uses. In an embodiment, the CNP prodrugs are conjugates of CNP peptides to poly(ethylene glycol) through a reversible linker.

Abstract: A wound treatment system includes a housing. A processor is located in the housing. A pressure monitoring system is coupled to the processor. A power delivery system is located in the housing and coupled to the processor. An oxygen concentrator is located in the housing and coupled to the power delivery system. The oxygen concentrator includes a plurality of oxygen outlets. The processor is configured to receive pressure information from the pressure monitoring system that is indicative of a pressure in a restricted airflow enclosure provided by a dressing and located adjacent a wound site; and use the pressure information to control the power provided from the power delivery system to the oxygen concentrator in order to control an oxygen flow created by the oxygen concentrator and provided through one of the plurality of oxygen outlets to the restricted airflow enclosure.

Abstract: A wound treatment system includes a housing. A processor is located in the housing. A pressure monitoring system is coupled to the processor. A power delivery system is located in the housing and coupled to the processor. An oxygen concentrator is located in the housing and coupled to the power delivery system. The oxygen concentrator includes a plurality of oxygen outlets. The processor is configured to receive pressure information from the pressure monitoring system that is indicative of a pressure in a restricted airflow enclosure provided by a dressing and located adjacent a wound site; and use the pressure information to control the power provided from the power delivery system to the oxygen concentrator in order to control an oxygen flow created by the oxygen concentrator and provided through one of the plurality of oxygen outlets to the restricted airflow enclosure.

Abstract: The present invention relates to prodrugs of C-type natriuretic peptide (CNP), pharmaceutical compositions comprising such CNP prodrugs and their uses. In an embodiment, the CNP prodrugs are conjugates of CNP peptides to poly(ethylene glycol) through a reversible linker.

Abstract: A filtration system (10) includes a filter (12) comprising a receptacle defining a chamber and a granular filtering medium contained in the chamber of the receptacle, the receptacle further defining an opening (22). An injection pump (26) is in communication with the opening (22) for injecting waste water to be treated into the chamber of the receptacle, the injection pump (26) being configured to pump the water into the chamber of the receptacle at a first flow rate. A discharge pump (32) is also in communication with the opening (22) for discharging water from the chamber of the receptacle, the discharge pump (32) being configured to discharge the water from the chamber of the receptacle at a second flow rate which is lower than the first flow rate of the injection pump (26).

Abstract: A filter (10) includes a receptacle (12) defining a chamber (14). A granular filtering medium (16) is contained in the chamber (14) of the receptacle (12). A disrupter arrangement (18) is mounted in the chamber (14) of the receptacle (12), the disrupter arrangement (18) serving to disrupt agglomeration of the granular filtering medium (16) within the chamber (14) of the receptacle (12).

Abstract: A wound treatment system includes a housing that defines an oxygen outlet. An oxygen production subsystem is included in the housing and coupled to the oxygen outlet. A control subsystem is coupled to the oxygen production subsystem and configured to receive pressure information that is indicative of a pressure in a restricted airflow enclosure that is coupled to the oxygen outlet. The control subsystem then uses the pressure information to control power provided to the oxygen production subsystem in order to control an oxygen flow that is created by the oxygen production subsystem and provided through the oxygen outlet to the restricted airflow enclosure.

Abstract: A non-invasive tissue oxygenation system for accelerating the healing of damaged tissue and to promote tissue viability is disclosed herein. The system is comprised of a lightweight portable electrochemical oxygen concentrator, a power management system, microprocessors, memory, a pressure sensing system, an optional temperature monitoring system, oxygen flow rate/oxygen partial pressure monitoring and control system, a display screen and key pad navigation controls as a means of providing continuous variably controlled low dosages of oxygen to a wound site and monitoring the healing process. A kink resistant oxygen delivery tubing, whereby the proximal end is removably connected to the device and the distal end with holes or a flexible, flat, oxygen-permeable tape is positioned at or near the wound bed as a means of applying near 100% pure oxygen to the wound site.

Abstract: A motor vehicle includes a motor vehicle body having an interior forming a passenger compartment. At least one camera is arranged on the outside of the motor vehicle body for imaging an area to the side and behind of the motor vehicle. In the interior of the motor vehicle, particularly in the region of an instrument panel, a monitor or display is arranged in or on an air outlet. The monitor is connected to the camera for continuously displaying the imaged area to occupants, and in particular a driver, in the passenger compartment.

Abstract: A wound treatment system includes a housing. A processor is located in the housing. A pressure monitoring system is coupled to the processor. A power delivery system is located in the housing and coupled to the processor. An oxygen concentrator is located in the housing and coupled to the power delivery system. The oxygen concentrator includes a plurality of oxygen outlets. The processor is configured to receive pressure information from the pressure monitoring system that is indicative of a pressure in a restricted airflow enclosure provided by a dressing and located adjacent a wound site; and use the pressure information to control the power provided from the power delivery system to the oxygen concentrator in order to control an oxygen flow created by the oxygen concentrator and provided through one of the plurality of oxygen outlets to the restricted airflow enclosure.

Abstract: A knowledge system is provided that is operable for producing how-to segments of information for use with a maintenance system, an equipment and asset tracking system, and a job function competency system to utilize a plurality of types of display devices for maintaining a plurality of types of industrial assets located at a plurality of locations. In one embodiment, a low energy communicator is mounted to said each of said plurality of industrial equipment assets and operable for providing more precise location information of a selected industrial equipment asset.

Abstract: A method of monitoring usage of a component of an aircraft can include: monitoring a usage of the component by using a torque measurement system to calculate torque events in a time period; categorizing the usage of the component by assigning a usage value based upon whether the number of torque events in the period of time is above or below a threshold; and determining a life used of the component.